OBJECTIVES: HPV vaccine acceptability was examined as part of a cohort study of HPV infection among adult males. RESULTS: Overall, 69% of men reported that they were likely or very likely to be vaccinated against HPV if a prophylactic vaccine were available. Men most frequently cited side effects (69%), efficacy (65%), and safety (63%) as the major factors that would influence their decision to be vaccinated against HPV. Issues of vaccine costs and efficacy were important considerations for men of vaccine-eligible ages (18-26 years). Men who cited cost as a major factor in their HPV vaccine decisions and those indicating cost as a potential barrier had greater intention to be vaccinated. Heterosexual men had less intention to be vaccinated compared to men who have sex with men. METHODS: Between July 2004 and June 2007, 445 adult males aged ≥18 years were enrolled primarily from a university-based population. A structured questionnaire addressed HPV vaccine awareness, attitudes, and intention to be vaccinated. CONCLUSION: Acceptability of HPV vaccination among males is generally high. Costs and sexual history may influence vaccine utilization.
OBJECTIVES:HPV vaccine acceptability was examined as part of a cohort study of HPV infection among adult males. RESULTS: Overall, 69% of men reported that they were likely or very likely to be vaccinated against HPV if a prophylactic vaccine were available. Men most frequently cited side effects (69%), efficacy (65%), and safety (63%) as the major factors that would influence their decision to be vaccinated against HPV. Issues of vaccine costs and efficacy were important considerations for men of vaccine-eligible ages (18-26 years). Men who cited cost as a major factor in their HPV vaccine decisions and those indicating cost as a potential barrier had greater intention to be vaccinated. Heterosexual men had less intention to be vaccinated compared to men who have sex with men. METHODS: Between July 2004 and June 2007, 445 adult males aged ≥18 years were enrolled primarily from a university-based population. A structured questionnaire addressed HPV vaccine awareness, attitudes, and intention to be vaccinated. CONCLUSION: Acceptability of HPV vaccination among males is generally high. Costs and sexual history may influence vaccine utilization.
Authors: Brenda Y Hernandez; K McDuffie; M T Goodman; L R Wilkens; P Thompson; X Zhu; W Wong; L Ning Journal: J Clin Microbiol Date: 2006-02 Impact factor: 5.948
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: B Y Hernandez; L R Wilkens; X Zhu; K McDuffie; P Thompson; Y B Shvetsov; L Ning; M T Goodman Journal: J Infect Dis Date: 2008-03-15 Impact factor: 5.226
Authors: C H Lenselink; C E Schmeink; W J G Melchers; L F A G Massuger; J C M Hendriks; D van Hamont; R L M Bekkers Journal: Public Health Date: 2008-07-10 Impact factor: 2.427
Authors: Daron G Ferris; Jennifer L Waller; Jeremiah Miller; Pratik Patel; George A Price; Lanier Jackson; Courtesia Wilson Journal: J Am Board Fam Med Date: 2009 Jan-Feb Impact factor: 2.657
Authors: Johannes A Bogaards; Mirjam Kretzschmar; Maria Xiridou; Chris J L M Meijer; Johannes Berkhof; Jacco Wallinga Journal: PLoS Med Date: 2011-12-20 Impact factor: 11.069
Authors: Piergiorgio Crosignani; Antonella De Stefani; Gaetano Maria Fara; Andrea M Isidori; Andrea Lenzi; Carlo Antonio Liverani; Alberto Lombardi; Francesco Saverio Mennini; Giorgio Palu'; Sergio Pecorelli; Andrea P Peracino; Carlo Signorelli; Gian Vincenzo Zuccotti Journal: BMC Public Health Date: 2013-07-11 Impact factor: 3.295